Lipid-regulatory mechanisms drive cerebrovascular disease in asymptomatic individuals at low risk for late-life dementia
Patricia GeniusiD, Blanca Rodríguez‐FernándeziD, Carolina MinguillóniD, Anna Brugulat‐SerratiD, Jordi HuguetiD, Manel EstelleriD, Carole H. SudreiD, Marta Cortés‐CanteliiD, Catarina Tristão‐PereiraiD, Inés García‐LunariD, Arcadi NavarroiD, Juan Domingo GispertiD, Natàlia Vilor‐TejedoriD, ALFA study
Abstract
BackgroundCerebrovascular lesions, particularly white matter hyperintensities (WMH), are often found in middle-aged individuals with a low cardiovascular risk profile. Understanding modifiable mechanisms leading to cerebrovascular disease is fundamental for implementing preventive strategies. This study aimed to elucidate the biological mechanisms underlying the presence of WMH in cognitively unimpaired (CU) middle-aged individuals. MethodsWe included 1,072 CU participants from the ALFA study with a low cardiovascular risk profile for late-life dementia based on the CAIDE score. We assessed genetic predisposition to WMH using polygenic scoring (PRSWMH). Covariate-adjusted Spearmans rank correlation tests evaluated the association between the PRSWMH and white matter hyperintensities volumes (WMHV). A logistic regression model was performed to explore the association between the PRSWMH and WMH severity, as measured with the Fazekas score. An enrichment analysis of the PRS-annotated genes unveiled the biological mechanisms leading to WMH burden. Group-specific effects were explored based on dementia-related cardiovascular risk factors. ResultsGenetic predisposition to WMH was associated with larger WMHV, even after controlling for confounders, but was not associated with WMH severity. Lipid-related biological processes were driving WMH genetic risk. Individuals genetically predisposed to WMH, who displayed larger WMHV, were either hypercholesterolemic, older than 55 or with lower educational attainment. InterpretationLipid-related mechanisms contribute to WMH in individuals at low cardiovascular risk for late-life dementia. These individuals should be considered for lifestyle- and lipid-modifying therapies to prevent dementia later in life. Funding"La Caixa" Foundation, the TriBEKa Imaging Platform, the Universities and Research Secretariat of the Catalan Government, the Spanish Research Agency.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Complexities of cerebral small vessel disease, blood pressure, and dementia relationship: new insights from genetics
Muralidharan Sargurupremraj, Aïcha Soumaré, … Stéphanie Debette·medRxiv·Aug 8, 2023
- Causes and consequences of vascular dementia across the life course: Evidence from a UK Biobank phenome-wide and Mendelian randomization study
Phazha LK Bothongo, Victoria Taylor‐Bateman, … Emma Louise Anderson·medRxiv·Jun 23, 2025
- Spatial distribution and cognitive impact of cerebrovascular risk-related white matter hyperintensities
Michele Veldsman, Petya Kindalova, … Thomas E. Nichols·NeuroImage ClinicalPeer-reviewed·Jan 1, 2020
- Impact of cardiometabolic factors and blood beta-amyloid on the volume of white matter hyperintensities in dementia-free subjects with cognitive complaints
Patricio Riquelme-Contreras, Michael Hornberger, … Andrea Slachevsky·bioRxiv·Jun 10, 2024
- White Matter Microstructure Fingerprint of Cerebral Small Vessel Disease
Aurélie Bussy, Camille Cathala, … Bogdan Draganski·BrainPeer-reviewed·Jun 5, 2026
- White matter hyperintensities are common in midlife and already associated with cognitive decline
Tracy C. d’Arbeloff, Maxwell L. Elliott, … Ahmad R. Hariri·Brain CommunicationsPeer-reviewed·Jan 1, 2019